Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Guillermo A. Morales
SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Editorial
Molecular Diversity
Organic Chemistry
Information Systems
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Medicine
Catalysis
Drug Discovery
Physical
Related publications
Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo
Cellular Physiology and Biochemistry
Physiology
Dual Inhibition of BRD4 and PI3K-AKT by SF2523 Suppresses Human Renal Cell Carcinoma Cell Growth
Oncotarget
Oncology
KRASG12D Promotes Immunosuppression in Colorectal Cancer
Cancer Discovery
Oncology
Elimination of Tumor by CD47/PD-L1 Dual-Targeting Fusion Protein That Engages Innate and Adaptive Immune Responses
mAbs
Allergy
Immunology
PI3K- Inhibitor Produces Long-Lasting Responses
Cancer Discovery
Oncology
Prostate Cancer Stem Cells Are Targets of Both Innate and Adaptive Immunity and Elicit Tumor-Specific Immune Responses
OncoImmunology
Oncology
Allergy
Immunology
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Clinical Cancer Research
Cancer Research
Oncology
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Nab-Paclitaxel Antitumor Response in Experimental Gastric Cancer
International Journal of Oncology
Cancer Research
Oncology
Pd32-01 Pre-Clinical Rationale for Combination Pi3k and Brd4 Inhibition in Advanced Prostate Cancer
Journal of Urology
Urology